{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T21:24:45Z","timestamp":1790112285217,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Heart Journal"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.ahj.2010.11.002","type":"journal-article","created":{"date-parts":[[2011,2,10]],"date-time":"2011-02-10T05:45:08Z","timestamp":1297316708000},"page":"241-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients"],"prefix":"10.1016","volume":"161","author":[{"given":"Matthew B.","family":"Sellers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Kristin","family":"Newby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ahj.2010.11.002_bb0005","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1001\/archinte.1995.00430050045005","article-title":"Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications","volume":"155","author":"Feinberg","year":"1995","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0010","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1001\/jama.285.18.2370","article-title":"Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study","volume":"285","author":"Go","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2010.11.002_bb0015","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1345\/aph.1K498","article-title":"Use of anticoagulation in elderly patients with atrial fibrillation who are at risk for falls","volume":"42","author":"Garwood","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ahj.2010.11.002_bb0020","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1161\/01.STR.27.10.1760","article-title":"Stroke severity in atrial fibrillation. The Framingham Study","volume":"27","author":"Lin","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2010.11.002_bb0025","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jamda.2005.08.002","article-title":"To anticoagulate or not to anticoagulate? A common dilemma for the provider: physicians' opinion poll based on a case study of an older long-term care facility resident with dementia and atrial fibrillation","volume":"7","author":"Dharmarajan","year":"2006","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.ahj.2010.11.002_bb0030","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1001\/archinte.163.13.1580","article-title":"Anticoagulant-related bleeding in older persons with atrial fibrillation: physicians' fears often unfounded","volume":"163","author":"Man-Son-Hing","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0035","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jama.280.22.1930","article-title":"Aspirin and risk of hemorrhagic stroke: a meta-analysis of randomized controlled trials","volume":"280","author":"He","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ahj.2010.11.002_bb0040","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/archinte.164.8.880","article-title":"The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage","volume":"164","author":"Rosand","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0045","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/S0002-9343(99)00267-3","article-title":"Major bleeding after hospitalization for deep-venous thrombosis","volume":"107","author":"White","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0050","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.amjmed.2005.02.022","article-title":"Incidence of intracranial hemorrhage in patients with atrial fibrillation who are prone to fall","volume":"118","author":"Gage","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0055","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1001\/archinte.159.7.677","article-title":"Choosing antithrombotic therapy for elderly patients with atrial fibrillation who are at risk for falls","volume":"159","author":"Man-Son-Hing","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0060","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1001\/archinte.1997.00440320143013","article-title":"The efficacy of aspirin in patients with atrial fibrillation. Analysis of pooled data from 3 randomized trials. The Atrial Fibrillation Investigators","volume":"157","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0065","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","article-title":"Antithrombotic therapy to prevent stroke in patients with atrial fibrillation: a meta-analysis","volume":"131","author":"Hart","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0070","doi-asserted-by":"crossref","first-page":"e257","DOI":"10.1161\/circ.114.4.257","volume":"114","author":"Fuster","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.ahj.2010.11.002_bb0075","doi-asserted-by":"crossref","first-page":"429S","DOI":"10.1378\/chest.126.3_suppl.429S","article-title":"Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy","volume":"126","author":"Singer","year":"2004","journal-title":"Chest"},{"key":"10.1016\/j.ahj.2010.11.002_bb0080","doi-asserted-by":"crossref","first-page":"970","DOI":"10.7326\/0003-4819-124-11-199606010-00004","article-title":"The risk for and severity of bleeding complications in elderly patients treated with warfarin. The National Consortium of Anticoagulation Clinics","volume":"124","author":"Fihn","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0085","doi-asserted-by":"crossref","first-page":"745","DOI":"10.7326\/0003-4819-141-10-200411160-00005","article-title":"Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation","volume":"141","author":"Fang","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0090","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1161\/01.STR.0000170642.39876.f2","article-title":"Avoiding central nervous system bleeding during antithrombotic therapy: recent data and ideas","volume":"36","author":"Hart","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2010.11.002_bb0095","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa022913","article-title":"Effect of intensity of oral anticoagulation on stroke severity and mortality in atrial fibrillation","volume":"349","author":"Hylek","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0100","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1001\/archinte.167.3.239","article-title":"Comparison of outcomes among patients randomized to warfarin therapy according to anticoagulant control: results from SPORTIF III and V","volume":"167","author":"White","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0105","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0140-6736(07)61233-1","article-title":"Warfarin versus aspirin for stroke prevention in an elderly community population with atrial fibrillation (the Birmingham Atrial Fibrillation Treatment of the Aged Study, BAFTA): a randomised controlled trial","volume":"370","author":"Mant","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2010.11.002_bb0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1345\/aph.1K157","article-title":"Quality of anticoagulation monitoring in nonvalvular atrial fibrillation patients: comparison of anticoagulation clinic versus usual care","volume":"42","author":"Nichol","year":"2008","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ahj.2010.11.002_bb0115","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ahj.2006.06.024","article-title":"Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials","volume":"152","author":"Flaker","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2010.11.002_bb0120","first-page":"687","article-title":"Warfarin versus aspirin for prevention of thromboembolism in atrial fibrillation: Stroke Prevention in Atrial Fibrillation II Study","volume":"343","author":"SPAF II Investigators","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2010.11.002_bb0125","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1161\/01.STR.31.4.817","volume":"31","author":"Yamaguchi","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.ahj.2010.11.002_bb0130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-9560-3-1","article-title":"The risk of hemorrhagic complications in hospital in-patients who fall while receiving antithrombotic therapy","volume":"3","author":"Bond","year":"2005","journal-title":"Thromb J"},{"key":"10.1016\/j.ahj.2010.11.002_bb0135","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.ahj.2005.06.026","article-title":"Rationale and design of ACTIVE: the Atrial Fibrillation Clopidogrel Trial with Irbesartan for Prevention of Vascular Events","volume":"151","author":"Connolly","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2010.11.002_bb0140","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(06)68845-4","article-title":"Clopidogrel plus aspirin versus oral anticoagulation for atrial fibrillation in the Atrial fibrillation Clopidogrel Trial with Irbesartan for prevention of Vascular Events (ACTIVE W): a randomised controlled trial","volume":"367","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/j.ahj.2010.11.002_bb0145","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1056\/NEJMoa0901301","article-title":"Effect of clopidogrel added to aspirin in patients with atrial fibrillation","volume":"360","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0150","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1056\/NEJMoa0905561","article-title":"Dabigatran versus warfarin in patients with atrial fibrillation","volume":"361","author":"Connolly","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ahj.2010.11.002_bb0155","author":"U.S. Food and Drug Administration Web site"},{"key":"10.1016\/j.ahj.2010.11.002_bb0160","author":"Wood"},{"key":"10.1016\/j.ahj.2010.11.002_bb0165","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ahj.2009.08.026","article-title":"Rationale and design of AVERROES: apixaban versus acetylsalicylic acid to prevent stroke in atrial fibrillation patients who have failed or are unsuitable for vitamin K antagonist treatment","volume":"159","author":"Eikelboom","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2010.11.002_bb0170","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.ahj.2009.11.025","article-title":"Rivaroxaban-once daily, oral, direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and Embolism Trial in Atrial Fibrillation: rationale and design of the ROCKET AF study","volume":"159","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2010.11.002_bb0175","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ahj.2009.07.035","article-title":"Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale","volume":"159","author":"Lopes","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/j.ahj.2010.11.002_bb0180","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1007\/s11606-009-0949-1","article-title":"Genetic testing before anticoagulation? A systematic review of pharmacogenetic dosing of warfarin","volume":"24","author":"Kangelaris","year":"2009","journal-title":"J Gen Intern Med"}],"container-title":["American Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870310010100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002870310010100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T05:43:49Z","timestamp":1757569429000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002870310010100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":36,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["S0002870310010100"],"URL":"https:\/\/doi.org\/10.1016\/j.ahj.2010.11.002","relation":{},"ISSN":["0002-8703"],"issn-type":[{"value":"0002-8703","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atrial fibrillation, anticoagulation, fall risk, and outcomes in elderly patients","name":"articletitle","label":"Article Title"},{"value":"American Heart Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ahj.2010.11.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}